My NCBI | Sign In
RSS Settings
  • Search: Lemon SM

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 226

    1.

    Gut microbes define liver cancer risk in mice exposed to chemical and viral transgenic hepatocarcinogens.

    Fox JG, Feng Y, Theve EJ, Fry RC, Fiala JL, Doernte AL, Williams M, Raczynski AR, McFaline JL, Essigmann JM, Schauer DB, Tannenbaum SR, Dedon PC, Weinman SA, Lemon SM, Rogers AB.

    Gut. 2009 Oct 22. [Epub ahead of print]PMID: 19850960 [PubMed - as supplied by publisher]Related articles

    2.

    Hepatitis C virus (HCV) proteins induce lipogenesis and defective triglyceride secretion in transgenic mice.

    Lerat H, Kammoun HL, Hainault I, Merour E, Higgs MR, Callens C, Lemon SM, Foufelle F, Pawlotsky JM.

    J Biol Chem. 2009 Oct 6. [Epub ahead of print]PMID: 19808675 [PubMed - as supplied by publisher]Related articlesFree article

    3.

    The requirement of cellular DDX3 for Hepatitis C Virus replication is unrelated to its interaction with the viral core protein.

    Angus AG, Dalrymple D, Boulant S, McGivern DR, Clayton RF, Scott MJ, Adair R, Graham S, Owsianka AM, Targett-Adams P, Li K, Wakita T, McLauchlan J, Lemon SM, Patel AH.

    J Gen Virol. 2009 Sep 30. [Epub ahead of print]PMID: 19793905 [PubMed - as supplied by publisher]Related articles

    4.

    Hepatitis C: recent successes and continuing challenges in the development of improved treatment modalities.

    Shimakami T, Lanford RE, Lemon SM.

    Curr Opin Pharmacol. 2009 Oct;9(5):537-44. Epub 2009 Sep 15.PMID: 19762279 [PubMed - in process]Related articles

    5.

    Coffee intake is associated with lower rates of liver disease progression in chronic hepatitis C.

    Freedman ND, Everhart JE, Lindsay KL, Ghany MG, Curto TM, Shiffman ML, Lee WM, Lok AS, Di Bisceglie AM, Bonkovsky HL, Hoefs JC, Dienstag JL, Morishima C, Abnet CC, Sinha R; HALT-C Trial Group.

    Hepatology. 2009 Nov;50(5):1360-9.PMID: 19676128 [PubMed - in process]Related articles

    6.

    Visualizing hepatitis C virus infections in human liver by two-photon microscopy.

    Liang Y, Shilagard T, Xiao SY, Snyder N, Lau D, Cicalese L, Weiss H, Vargas G, Lemon SM.

    Gastroenterology. 2009 Oct;137(4):1448-58. Epub 2009 Jul 24.PMID: 19632233 [PubMed - indexed for MEDLINE]Related articles

    7.

    Toll-like receptor 3 mediates establishment of an antiviral state against hepatitis C virus in hepatoma cells.

    Wang N, Liang Y, Devaraj S, Wang J, Lemon SM, Li K.

    J Virol. 2009 Oct;83(19):9824-34. Epub 2009 Jul 22.PMID: 19625408 [PubMed - indexed for MEDLINE]Related articles

    8.

    Lack of adaptation of chimeric GB virus B/hepatitis C virus in the marmoset model: possible effects of bottleneck.

    Weatherford T, Chavez D, Brasky KM, Lemon SM, Martin A, Lanford RE.

    J Virol. 2009 Aug;83(16):8062-75. Epub 2009 May 27.PMID: 19474092 [PubMed - indexed for MEDLINE]Related articles

    9.

    Impaired replication of hepatitis C virus containing mutations in a conserved NS5B retinoblastoma protein-binding motif.

    McGivern DR, Villanueva RA, Chinnaswamy S, Kao CC, Lemon SM.

    J Virol. 2009 Aug;83(15):7422-33. Epub 2009 May 20.PMID: 19458004 [PubMed - indexed for MEDLINE]Related articles

    10.

    Variants in interferon-alpha pathway genes and response to pegylated interferon-Alpha2a plus ribavirin for treatment of chronic hepatitis C virus infection in the hepatitis C antiviral long-term treatment against cirrhosis trial.

    Welzel TM, Morgan TR, Bonkovsky HL, Naishadham D, Pfeiffer RM, Wright EC, Hutchinson AA, Crenshaw AT, Bashirova A, Carrington M, Dotrang M, Sterling RK, Lindsay KL, Fontana RJ, Lee WM, Di Bisceglie AM, Ghany MG, Gretch DR, Chanock SJ, Chung RT, O'Brien TR; HALT-C Trial Group.

    Hepatology. 2009 Jun;49(6):1847-58.PMID: 19434718 [PubMed - indexed for MEDLINE]Related articles

    11.

    Trans-complementation of an NS2 defect in a late step in hepatitis C virus (HCV) particle assembly and maturation.

    Yi M, Ma Y, Yates J, Lemon SM.

    PLoS Pathog. 2009 May;5(5):e1000403. Epub 2009 May 1.PMID: 19412343 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    A cooperative interaction between nontranslated RNA sequences and NS5A protein promotes in vivo fitness of a chimeric hepatitis C/GB virus B.

    Warter L, Cohen L, Benureau Y, Chavez D, Yang Y, Bodola F, Lemon SM, Traboni C, Lanford RE, Martin A.

    PLoS One. 2009;4(2):e4419. Epub 2009 Feb 10.PMID: 19204793 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Serum fibrosis marker levels decrease after successful antiviral treatment in chronic hepatitis C patients with advanced fibrosis.

    Fontana RJ, Bonkovsky HL, Naishadham D, Dienstag JL, Sterling RK, Lok AS, Su GL; Halt-C Trial Group.

    Clin Gastroenterol Hepatol. 2009 Feb;7(2):219-26. Epub 2008 Nov 7.PMID: 19068241 [PubMed - indexed for MEDLINE]Related articles

    14.

    In vitro selection of a neutralization-resistant hepatitis C virus escape mutant.

    Gal-Tanamy M, Keck ZY, Yi M, McKeating JA, Patel AH, Foung SK, Lemon SM.

    Proc Natl Acad Sci U S A. 2008 Dec 9;105(49):19450-5. Epub 2008 Dec 3.PMID: 19052239 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Prolonged therapy of advanced chronic hepatitis C with low-dose peginterferon.

    Di Bisceglie AM, Shiffman ML, Everson GT, Lindsay KL, Everhart JE, Wright EC, Lee WM, Lok AS, Bonkovsky HL, Morgan TR, Ghany MG, Morishima C, Snow KK, Dienstag JL; HALT-C Trial Investigators.

    N Engl J Med. 2008 Dec 4;359(23):2429-41.PMID: 19052125 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    The accelerating pace of HCV research: a summary of the 15th International Symposium on Hepatitis C Virus And Related Viruses.

    Lanford RE, Evans MJ, Lohmann V, Lindenbach B, Gale M Jr, Rehermann B, Chang KM, Lemon SM.

    Gastroenterology. 2009 Jan;136(1):9-16. Epub 2008 Nov 19. No abstract available. PMID: 19026648 [PubMed - indexed for MEDLINE]Related articles

    17.

    Genotype 1a HCV (H77S) infection system.

    Yi M, Lemon SM.

    Methods Mol Biol. 2009;510:337-46.PMID: 19009273 [PubMed - indexed for MEDLINE]Related articles

    18.

    Tumor suppressors, chromosomal instability, and hepatitis C virus-associated liver cancer.

    McGivern DR, Lemon SM.

    Annu Rev Pathol. 2009;4:399-415. Review.PMID: 18928409 [PubMed - indexed for MEDLINE]Related articles

    19.

    Incidence of hepatocellular carcinoma and associated risk factors in hepatitis C-related advanced liver disease.

    Lok AS, Seeff LB, Morgan TR, di Bisceglie AM, Sterling RK, Curto TM, Everson GT, Lindsay KL, Lee WM, Bonkovsky HL, Dienstag JL, Ghany MG, Morishima C, Goodman ZD; HALT-C Trial Group.

    Gastroenterology. 2009 Jan;136(1):138-48. Epub 2008 Sep 18.PMID: 18848939 [PubMed - indexed for MEDLINE]Related articles

    20.

    Antiviral suppression vs restoration of RIG-I signaling by hepatitis C protease and polymerase inhibitors.

    Liang Y, Ishida H, Lenz O, Lin TI, Nyanguile O, Simmen K, Pyles RB, Bourne N, Yi M, Li K, Lemon SM.

    Gastroenterology. 2008 Nov;135(5):1710-1718.e2. Epub 2008 Jul 22.PMID: 18725224 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    89 free full-text articles in PubMed Central

    Find related data

    Search details

    » See more...

    Recent activity